Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

被引：4
|
作者：
Masafumi Kawamura
Keisuke Eguchi
Yotaro Izumi
Yasushi Yamato
Teruaki Koike
Hirozo Sakaguchi
Enjo Hada
Koichi Kobayashi
机构：
[1] Keio University Hospital,Division of General Thoracic Surgery
[2] Niigata Prefectural Cancer Center Hospital,undefined
[3] Mitsui Memorial Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 60卷
关键词：
Non-platinum doublet; Adjuvant chemotherapy; Non-small-cell lung cancer; Docetaxel; Gemcitabin; Surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：495 / 501
页数：6
相关论文
共 50 条
  • [21] A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
    Francesco Grossi
    Filippo de Marinis
    Vittorio Gebbia
    Ferdinando Riccardi
    Orazio Caffo
    Teresa Gamucci
    Francesco Ferraù
    Mario Nardi
    Luca Moscetti
    Luca Boni
    Davide Dondi
    Enzo Galligioni
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 369 - 375
  • [22] A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
    Grossi, Francesco
    de Marinis, Filippo
    Gebbia, Vittorio
    Riccardi, Ferdinando
    Caffo, Orazio
    Gamucci, Teresa
    Ferrau, Francesco
    Nardi, Mario
    Moscetti, Luca
    Boni, Luca
    Dondi, Davide
    Galligioni, Enzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 369 - 375
  • [23] Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer
    Naim Younes, R.
    Gross, J. L.
    Abrao, F. C.
    Rodrigues Pereira, J.
    MINERVA CHIRURGICA, 2013, 68 (02) : 169 - 174
  • [24] Phase II clinical trial on docetaxel in the treatment of non-small-cell lung cancer (NSCLC).
    Chen, Y
    Zhao, Y
    Chen, Z
    Liao, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 708S - 708S
  • [25] Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial
    Matsubara, Taichi
    Yamaguchi, Masafumi
    Shimokawa, Mototsugu
    Okamoto, Isamu
    CLINICAL LUNG CANCER, 2024, 25 (03) : 280 - 283
  • [26] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer: an AASLC phase II trial
    Krajnik, G
    Malayeri, R
    Thaler, J
    Mohn-Staudner, A
    Greil, R
    Schmeikal, S
    Marhold, F
    Deutsch, J
    Preiss, P
    Zoechbauer-Mueller, S
    Huber, H
    Pirker, R
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 647 - 649
  • [27] A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
    Qin, Angel
    Wells, Leah
    Malhotra, Binu
    Gadgeel, Shirish
    Schneider, Bryan J.
    Ramnath, Nithya
    Rice, John D.
    Kalemkerian, Gregory P.
    CLINICAL LUNG CANCER, 2024, 25 (02) : 128 - 134
  • [28] Is adjuvant radiochemotherapy superior to postoperative radiotherapy alone in patients with completely resected stage II or IIIA non-small cell lung cancer?
    Baumann, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2001, 177 (04) : 220 - 221
  • [29] Adjuvant therapy in completely resected non-small-cell lung cancer
    Giorgio V. Scagliotti
    Silvia Novello
    Current Oncology Reports, 2003, 5 (4) : 318 - 325
  • [30] Adjuvant chemotherapy in completely resected non-small-cell lung cancer
    Pisters, KMW
    Le Chevalier, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) : 3270 - 3278
12345